← Evidence map

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

BBS5 as a robust prognostic biomarker in esophageal squamous cell carcinoma: validation in two independent cohorts.

Kotaro Aoki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42611129